Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$275,878,760
+$19,709,868 QoQ
Shares Held
4,570,556
+3.8% QoQ
Ownership
4.72%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#4
of 314 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. XENE ranks #2 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELVN |
Enliven Therapeutics, Inc.
|
6,430,636 | $326,354,777 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
4,570,556 | $275,878,760 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,253,649 | $191,988,358 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,663,632 | $184,713,060 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
6,606,945 | $173,234,097 | |
| 6 | ASND |
Ascendis Pharma A/S
|
616,908 | $164,541,701 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
2,063,609 | $153,697,598 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
482,751 | $145,322,533 |
All Filings in XENE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $275,878,760 | 4,570,556 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $256,168,892 | 4,405,312 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $110,512,405 | 2,465,694 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $102,252,654 | 2,546,766 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $84,611,912 | 2,703,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $88,002,958 | 2,623,039 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $105,748,154 | 2,697,657 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $96,245,673 | 2,444,645 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $98,880,901 | 2,536,058 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $112,451,249 | 2,612,108 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $141,248,885 | 3,066,628 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $102,607,997 | 3,003,747 | Shares | Defined | 2023-11-22 | |
| 2023-06-30 | $116,349,733 | 3,022,071 | Shares | Defined | 2023-12-13 | |
| 2023-03-31 | $107,971,916 | 3,016,818 | Shares | Defined | 2023-12-13 | |
| 2022-12-31 | $120,098,811 | 3,045,874 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $96,124,264 | 2,662,722 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $77,268,594 | 2,540,059 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $66,950,103 | 2,190,059 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $52,734,494 | 1,688,044 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||